Enterodez powder 5g, No. 1

• Conditions accompanied by intoxication, incl. burn disease in the intoxication phase,

• toxic forms of acute infectious gastrointestinal diseases, l

• study disease in the intoxication phase,

• postoperative intoxication,

• toxicosis of pregnant women,

• hemolytic disease and toxemia of newborns,

• sepsis.

Inside, 1-2 hours after taking food or medications.

Before use, 5 g of powder (1 teaspoon) is dissolved in 100 ml of cold boiled water and taken orally 1-3 times a day for 2-7 days (until the symptoms of intoxication disappear).

If necessary, the course of treatment can be continued up to 10-15 days on the recommendation of a doctor.

Powder for preparation of oral solution 1 pack.

low molecular weight medical povidone (polyvinylpyrrolidone) with a molecular weight of 12600 ± 2700 5 g

• Bronchial asthma,

• sharp jade,

• cerebral hemorrhage,

• severe cardiovascular insufficiency,

• hypersensitivity to povidone.

Trade name of the drug

EnterodezЃ

International non-proprietary name

Povidone

Dosage form

Powder for oral solution

Composition

Low molecular weight medical polyvinylpyrrolidone (m.m. 12600 ± 2700) - 5 g. And 50 g.

Description

White or slightly yellowish powder with a weak specific odor, hygroscopic.

Pharmacotherapeutic group

Enterosorbent

ATX code

A07BC

Pharmacodynamics:

Enterodesis is able to bind toxins entering the gastrointestinal tract and formed in the body and remove them through the intestines. The therapeutic effect of the drug appears 15-30 minutes after administration.

Pharmacokinetics:

Not absorbed. Does not metabolize. Completely excreted from the gastrointestinal tract.

Indications:

• Toxic forms of acute infectious intestinal diseases (salmonellosis dysentery)

• intoxication with hepatic and renal failure.

Contraindications:

• Hypersensitivity

• children under 18 years of age (safety and efficacy have not been established).

Pregnancy and lactation:

There is no sufficient experience in the use of the drug during pregnancy and lactation. It can be used in pregnant and lactating mothers as directed by the attending physician if the expected therapeutic effect for the mother outweighs the risk of developing possible side effects for the fetus and newborn.

Method of administration and dosage:

Inside, 1-2 hours after taking food or medications. Before use, 5 g of powder (1 teaspoon) is dissolved in 100 ml of cold boiled water and taken orally 1-3 times a day for 2-7 days (until the symptoms of intoxication disappear).

If necessary, the course of treatment can be continued up to 10-15 days on the recommendation of a doctor.

Side effects:

Rapidly passing nausea is rare - vomiting. Photosensitivity reactions.

Interaction:

The use in conjunction with other drugs prescribed by mouth can dramatically slow down the rate and / or reduce the degree of their absorption from the gastrointestinal tract.

Special instructions:

The prepared solution should be stored in the refrigerator at 4 ? C for no more than 3 days.

Release form / dosage:

Powder for preparation of oral solution.

Packaging:

Powder for preparation of oral solution in packs of 5 and 50 g.

Packages together with instructions for use in group packaging.

Storage conditions:

At a temperature of -10 ? C to + 30 ? C in a dry, dark place out of the reach of children.

Shelf life:

2 years. Do not use the drug after the date indicated on the package.

Vacation conditions

Without recipe.